Microbiology
Showing page 55 of 235 pages of list content
-
Multidrug treatment with nelfinavir and cepharanthine against COVID-19
This article's authors -
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
This article's authors -
TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets
This article's authors -
Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics
This article's authors -
Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain
This article's authors -
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
This article's authors -
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
This article's authors -
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
This article's authors -
Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2
This article's authors -
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1
This article's authors